Wassana Yantasee, Ph.D.

  • Professor of Biomedical Engineering, School of Medicine
  • Program in Molecular and Cellular Biosciences, School of Medicine


Wassana Yantasee, Ph.D., M.B.A, is a Professor of Biomedical Engineering, Oregon Health and Science University (OHSU) School of Medicine. She graduated from Chulalongkorn University, Thailand with BS (1995) and Oregon State University (OSU) with MS (1999) and PhD in Chemical Engineering (2001) under Prof. Gregory L Rorrer. In 2001, she also received her MBA from OSU.

From 2001-2009, she worked as a research scientist at the Pacific Northwest National Laboratory (PNNL), operated by Battelle Memorial Institute for the U.S. Department of Energy. Her last position was SE 4 (two levels below the highest level, SE 6). While at PNNL, she was the winner of the Ronald L. Brodzinski Early Career Scientific Achievement Award (2007).

In October of 2009, she was appointed a faculty position at the Department of Biomedical Engineering, OHSU and as ONAMI Nanomedicine Signature Researcher. Dr. Yantasee is an inventor of 8 invention disclosure reports, 2 US patents, and 3 US patent applications on the use of nanomaterials for environmental and medical applications. She has authored 6 book chapters and 46 peer-reviewed journal articles. She has been a scientific reviewer for NIEHS-Multiproject Program Grants (P42), Superfund Basic Research Program, Bioengineering Sciences and Technologies (BST), Biomaterials and Biointerfaces Study Section (including a charter member position), the DOE's Small Business Innovation Research, and NIH's Small Business Innovation Research. In 2004, she was inducted into the Council of Outstanding Early Career Engineers at OSU. 

Yantasee is also the President of PDX Pharmaceuticals, which recently has won a fast track SBIR (phase I/II) award from NIH/NCI to develop siRNA-nanoparticle therapeutic for treating of breast cancer.



  • {{ pub.journalAssociation.journal.name.text[0].value }}